publications
October 10, 2017
UAMS Study Identifies One Reason Myeloma Patients Respond Differently to Treatment
Oct. 10, 2017 | Researchers with the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) have identified one reason myeloma patients respond differently to treatment — the cancer cells can vary in type and intensity depending on where in the bone marrow they are located. The team headed by Leo Rasche, M.D., and…
January 5, 2017
Research Opens New Possibilities for Treatment for Osteoporosis and Other Bone Diseases
Jan. 5, 2017 | A team of University of Arkansas for Medical Sciences (UAMS) researchers have made key advances in the understanding of how bone is maintained, opening new avenues for the development of treatments for osteoporosis, arthritis and bone metastasis of certain types of cancer. Haibo Zhao, M.D., Ph.D., associate professor of medicine and physiology…
August 24, 2016
UAMS Researcher Develops Model for Predicting Drug Toxicity
Aug. 24, 2016 | Toxicity is a common reason many drugs are pulled from market and new drug leads fail. Avoiding this outcome requires knowing when drugs are likely to cause toxicity. As a step in this direction, University of Arkansas for Medical Sciences (UAMS) researcher Grover P. Miller, Ph.D., and collaborators have published a…